ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in August 2022. Updated August 31.
A roundup of FDA’s actions in August 2022.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in August 2022. Updated August 31.
A roundup of FDA’s actions in August 2022.